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Objectives . Tine purpose of this study was to test the hypothesis
that endothelial dysfunction occurs in humans before the devel®
opment of structural coronary atherosclerosis when risk factors
for this disease are present .
Baekgrosend, Animal studies ]love demonstrated that known
risk factors for coronary atheroselteosis (hyperlipidemin, hyper-
tension, diabetes) result in impaired endothellmn-dependent vas .
cular reactivity before the developmeall of struciueral adleros&-
rosis . Previous studies in patients have been tumble to distinguish
early structural atherosclerotic disease from dysfunctional endo-
thelium .
Method-. Twenty-six patients with angiographicafly normal
coronary arteries were studied at cardiac catheterization . The
epicardial arteries were imaged using high resolution intravascu-
lar ultrasound to detect early structural changes and to determine
changes in lumen size during pharmacologii° provocation . A
selective intracoronar' Doppler velocity catheter was subse-
quently used to determine coronary blood flow velocity changes
in response to the same pharmacologic provocation . Group 1
(9 patients) had no risk factors for atherosclerosis . Group 11
(17 patients) had one or more risk factors present .
Restails . Although both Groups I and 11 had a normal micro.
vascular vasodilator response to adenosine or papaverine infusion
Hypercholesterolemia, hypertension, diabetes and a family
history of premature coronary artery disease are known risk
factors for atherosclerotic coronary artery disease (1) . In
animal studies, hypercholesterolemia, hypertension and di-
abetes each have been shown to impair endothelium-
dependent vasodilation, even in the absence of atheroscle-
rotic narrowing of the vessel (2-7) . Patients with risk factors
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(estimated coronary flow increase 396 ± 200% vs. 326 ± 161%
[mean ± SD], respectively, p = 0 .103), only Group I patients had
an intact response to acetylcholine infusion (370 ± 203% vs . 75 ±
93% in Group 11, p = 0 .001) . Group 11 patients had an abnormal
epicardia3 artery cross-sectional area
vasoconstriction
response to
acoylehoNne infusion (-16 .6 ± 12.4% [13 patients) vs . 1 .3 ±
11.5% in Group I, p = 0.0007). An additional four Group 11
patients had severe spasm during acetylcholine infusion . Epicar-
dial vasodilator response to nitroglycerin infusion, however, was
preserved in Group 11(14 .6 ± 43% vs . 9.6 ± W in Group 1,
p = 0 .212). All Group I patients had normal vessels by intravas-
cular ultrasound. Of the 17 patients in Group 11, 7 had minimal
disease on ultrasound (intimal thickening or small eccentric
plaque) in the study vessel . These patients did not respond
differently from the 10 Group 11 patients without demonstrable
disease on ultrasound .
Conclusions . Patients with risk factors for coronary artery
disease, normal coronary angiograms and no measurable disease
by intracoronary ultrasound exhibit selective endothelial dysfunc-
tion at both the epicardial and microvascular levels . These find-
ings may have implications for the treatment of "preclinical"
coronary atherosclerosis .
(j Am Coll Cardlol 1994,23.833-43)
for coronary atherosclerosis but angiographically normal
coronary arteries have also been shown to have endothelial
dysfunction (8-10) . Angiography is an insensitive method
for detecting early atherosclerosis or diffuse involvement of
an entire vessel with disease (11-14) . However, intravascu-
lar ultrasound imaging is more sensitive for detecting early
atherosclerosis. Previous in vivo studies have demonstrated
that ultrasound imaging can identify significant atheroscle-
rosis in angiographically smooth coronary artery segments
(13,14) . Therefore, undetected atherosclerosis may account
for endothelial dysfunction in some patients with angio-
graphically normal coronary arteries .
Tne purpose of this study was to determine whether
endothelial dysfuncticn seen in patients with risk factors for
coronary artery disease and angiographically normal coro-
nary arteries could be explained by early atherosclerosis not
detected by angiography or was the result of a primary
0735-1097/941$7 .00
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alteration in endothelial function, possibly induced by the
presence of coronary risk factors alone . We used intracoro-
nary ultrasound imaging to inspect for very early atheroscle-
rosis in angiographically normal coronary arteries . Our
hypothesis was that selective endothelial dysfunction could
occur in the absence of angiographic or ultrasound evidence
of coronary atherosclerosis in patients with known coronary
risk factors.
Methods
Pa"ts. Twenty-six patients undergoing coronary an-
giography for evaluation of chest pain who were found to
have angiogmphically normal vessels were included in the
study. Patients with Prinzmetal angina, left ventricular dys-
function or significant valvular disease were excluded be-
cause patients with these disorders have been shown to have
abnormal coronary blood flow reserves . Written informed
consent was obtained from all patients before the study . The
study protocol was approved by the University Hospitals of
Cleveland Institutional Review Board . Careful history was
obtained for each patient with respect to risk factors for
coronary artery disease based on generally accepted criteria
(1). The following risk factors were prospectively ascer-
tained by history : I) hypercholestcrolemia = serum choles-
terol >240 mgtdi; 2) hypertension = previously elevated
blood pressure requiring antihypertensive therapy (all pa-
tients with hypertension were being treated) ; 3) family
history = a parent or sibling of the patient with documented
clinical evidence of coronary artery disease before 60 years
of age; 4) cigarette smoking := patients were classified as
nonsmokers if they had never smoked or had stopped
smoking (all other patients were classified as smokers) .
Patients were assigned to two groups on the basis of the
absence (Group I) or presence (Group II) of risk factors for
coronary artery disease .
%ty la0mmi. Vasoactive drugs were withdrawn 24 h
before cardiac catheterization . Left heart catheterization,
left ventriculogmphy and coronary angiogmphy were per-
formed by using the Judkins technique . Arterial pressure and
electrocardiogram (ECG) were monitored continuously .
After routine angiography, the patient underwent full
heparinization to maintain an activated clotting time >300 s .
A 7F pacing catheter was positioned in the right ventricle
and set in demand mode at a rate of 40/min. An 8F guiding
catheter (Interventional Medical) was introduced for cannu-
lazation of the coronary ostium . A 0.014-in. (0.036 cm)
floppy guide wire was placed in the study vessel, and a 5 .5F
or 33F intraluminal ultrasound imaging catheter (Visions,
Endosonics) was advanced over the guide wire to obtain
coaxial images of the coronary artery (15). The images were
stored on 0 .5-in . (1 .27 cm) videotape for subsequent analy-
sis. As the ultrasound catheter was advanced, coaxial two-
dimensional images of the proximal, mid and distal segments
of the study vessel were obtained
. The imaging catheter then
was positioned in the midsegment, and after establishing a
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stable scan plane, intracoronary vasoactive medications
were administered through the guiding catheter (16,17) . To
ensure appropriate intracoronary drug delivery, contrast
injections were performed before drug infusion to verify
catheter position .
In 13 patients, acetylcholine (5 jug/ml) was infused at
5 ml/min for 2 min to achieve an estimated blood concentra-
tion in the coronary bed of 10' mol/liter, assuming left main
coronary artery flow of 150 ml/min . In 13 patients, graded
concentrations of acetylcholine (0.5, 5 and 50 4ml) were
given to achieve estimated blood concentrations of 10-7
,
10-6 and 10 -5 mol/liter, Stepwise acetylcholine infusions were
terminated when either vessel occlusion occurred or the high-
est dose (104 111011100 was reached . Severe vasospasm and
vessel occlusion were treated when necessary with I mg of
intracoronary atropine . If atropine was required, the procedure
was terminated. After return to basal state, papaverine (the
first 11 patients) or adenosine (15 patients), or both, was
administered. In the later part of the study, adenosine was
chosen in place of papaverine when it became commercially
available and was shown to have a more favorable safety
profile, rapid onset of action and shorter half-life . Papaverine
was given as a 14-mg bolus. Adenosine (20 and 30 peml) was
Oven as graded 2-min infusions (100 and 150 4min). After
return to basal state, intracoronary nitroglycerin (150 to 200-po
bolus) was administered . The arterial cross-sectional area was
imaged contininusly during pharmacologic manipulation .
The ultrasound catheter then was removed, and a 3F
Doppler catheter (Millar DC-201) was placed in the same
position as the ultrasound scan plane, and this position was
verified by contrast angiography. After obtaining a stable
signal, the position and range gate control were not changed
for the remainder of the study. The identical drug infusion
protocol then was repeated while mean and phasic flow
velocity, mean arterial pressure and ECG were recorded
continuously (16-18) .
Ultimmwnd Image analysis . All images were reviewed for
the presence of atherosclerosis by three observers . Athero-
sclerosis was considered to be present if the intimal leading
edge echo and echolucent zones were >500 pm in thickness
(14) or when plaque was evident in any portion of the vessel .
The interface between the lumen and vessel wall .,as traced
with an electronic cursor . A customized computer program
then calculated the lumen cross-sectional area. Lumen
cross-sectional area' was measured just before and during the
last 15 s of intracoronary administration of acetylcholine,
papaverine or adenosine and nitroglycerin . For each mea-
surement, results from three successive end-diastolic frames
were averaged . The interobserver and intraobserver vari-
ability for lumen area measures has been reported previously
and is very low (r = 0.99 and r = 0.98, respectively) (19).
Statistics and calculations . Mean coronary blood flow
velocities were computed by zero crossing, and mean aortic
pressures were used for calculations . In patients receiving
stepwise increases of acetylcholine, the concentration re-
sulting in the greatest change in velocity was used for
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Table 1 . Patient Demographics
,'in Group 11, four patients had two risk factors, and one had three risk
factors . 'gyp = 0 .242 versus group 11 . values presented are mean value ± SID or
number of patients . F = afemale ; M = male .
calculation . A coronary flow index (estimated volume flow)
was calculated as the product of mean coronary flow veloc-
ity and ultrasound-derived lumen cross-sectional area . (Use
of this index compensates for changes in coronary flow
velocity due to epicardial lumen area alterations at the site of
velocity sampling .) A coronary vascular resistance index
was calculated as the ratio of coronary flow index and mean
arterial pressure. Velocity and lumen area measurements
obtained during vessel occlusion from spasm induced by
acetylcholine in four group 11 patients were excluded from
the group data . Comparisons of drug effect were made using
a paired t test. With correction for multiple comparisons,
values of p < 0.017 were considered significant . Compari-
sons between groups were performed by using a repeated
measures analysis of variance with a significance level of p <
0.05 . All data are expressed as mean value ± 1 SD .
Results
Patients were assigned to two groups on the basis of the
presence or absence of risk factors (Table 1) .
Figure 1 . Images obtained in a patient from
Group 11. Normal left main coronary artery
angiogram with ultrasound scan planes shown
by bars at A and B . At level A in the left main
coronary artery, the ultrasound is normal . At
level B a soft eccentric plaque is seen (black
arrowheads) .
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Group I : risk factors absent (9 patients) . Group I patients
had normal coronary arteries by both iniracofonary ultra-
sound imaging and angiography and had no dskk factors for
coronary artery disease . The study vessel was the left
anterior descending coronary artery in all Group I patients .
Group II : risk factors present (I7 patients) . All Group 11
patients had one or more risk factors for coronary artery
disease and no evidence of atherosclerosis by angiography in
the study vessel . The study vessel was the left anterior
descending coronary artery in 12 patients, the left circumflex
coronary artery in 4 and the right coronary artery in 1 .
Because of severe vasoconstrictive responses to acetylcho-
line, ultrasound area and Doppler velocity data were unin-
terpretable in four patients .
Evidence of atherosclerosis . In Group 1, none of the nine
patients had evidence of atherosclerosis, by either ultra-
sound or angiography . Ultrasound documented a thin intimal
leading edge and a thin echolucent media . In Group 11, 7 of
17 patients had evidence of early atherosclerosis by ultra-
sound (intimal thickening in 5 and small, focal soft plaque in
2) (Fig . 1) . By angiography, none of the patients in Group 11
had evidence of atherosclerosis in the study vessel, but two
of the seven patients with abnormal ultrasound images had
minimal lumen irregularities in a nonstudy vessel .
Responses to pharmacologic stimulatien . Individual pa-
tient data are displayed in Table 2 . Percent change in lumen
area, mean coronary blood flow and paean arterial blood
pressure for the group data are shown in Table 3 .
Hemodynamic variables . There was no significant
change in heart rate or mean arterial pressure with acetyl-
choline, papaverine, or adenosine infusion in either group
(Table 3). Nitroglycerin caused a significant decrease in
mean arterial pressure (°12.2 ± 5 .9% in Group 1, p <
0.000 1 ; -10.9 ± ~. I% in Group 11, p < 0 .0001) accompan-
ied by a significant increase in heart rate (13 .9 ± 13.3% in
Group 1, p < 0,02 ; 7 .8 ± 6.9% in Group 11, p < 0 .001. The
Group I
(n = 9 ;
Group 11
(n = 17)
M/F
?7
Age ly)
49 :t 16 52 ~ I I
Risk factors*
Smoking 0 2
Family history 0 II
Hypertension 0 6
Hyperchoiesteroiemia 0 4
Mean cholesterol (mg/dl)
198 ± 20'.
241 ± 104
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Wie 2
. Percent Change prom Baseline in Epicardial Coronary Artery Lumen, Mean Coronary plow Velocity and Mean Arterial
Pressure in Response to Acetylcholine,
Papaverine/Adenosine and Nitroglycerin
Op < 0. 1 . tp < 0,005 . $Patient had severe vasespasm with acetyleholine (ACH)
. ABNL = abnormal : EPI =epicardial coronary artery lumen : F = female:
ICUS - intracorowty ultrasound : M - male: MAP = mean arterial pressure . MCFV = mean coronary flow velocity ; NL = normal
: NW = nitroglycerin
:
PAPADE - papaverine or adenosine ; Pt = patient ; %A = % change.
two groups were not different in their response to nitroglyc-
erin .
Epkardial artery lumen area . Four patients in Grout ii
had transient occlusion of the study vessel associated with
chest pain and ECG changes during infusion at 10 - ' or 10
-6
moMiter concentration. Their lumen area data are not in.
cluded. In Group 1, acetylcholine caused vasodilation of the
epicardial artery in all but two patients, with an increase in
lumen area from 11.7 :6 3.6 to 12 .1 ± 4.3 mm' (1 .3 ± 11 .5%,
p = 0.218) . In all but two patients in Group 11, acetylcholine
caused vasoconstriction, with a mean decrease in lumen area
from 9S ± 2.2 to 8.3 ± 2.3 mm2 (-16.6±12.49®,p<0001)
(Fig. 2 and 3). The changes in lumen area after acetylcholine
infusion in Group I were significantly different from those in
Group H (1 .3 ± 11 .5% vs . -16 .6 ± 12.4%, respectively, p =
0.0007). There was no significant correlation between serum
cholesterol and change in lumen area after acetylcholine
infusion .
The direct-acting vasodilator nitroglycerin caused vaso-
dilation of the epicardial artery in both groups (Fig . 3 and 4) .
In Group 1, nitroglycerin suited in an increase in lumen
area from 12.1 ± 3.5 to 0.2 ± 3.9 mm2 (9.6 ± 3.5%, p <
0.0005). In Group 11, the lumen area increased from 10 .0 ±
2.1 to I1 .5 2: 2.4 qmn' (14 .6 ± 4.3%, p < 0 .0001). Responses
for Groups I and II were not significantly different (p = 0 .212) .
Papaverine or adenosine administration resulted in epi-
cardia! vasodilation, with an increase in lumen area from
12A ± 4.0 to 12 .6 ± 3 .9 tnm 2 (6.1 ± 6,K p < 0 .002) in
Group I and from 9 .7 ± 2.5 to 10.0 ± 2.5 mm2 in Group 11
(3.5 ± 8.4%, p = 0.193) (Fig . 5) . The changes in lumen area
after papaverine or adenosine infusion were not significantly
different between Groups I and II (p = 0 .425).
%A With ACH
%A With PAPIADE
%A With NTG
Pt No. EPI Area
MCFV MAP EPI Area
MCFV MAP EPI Area MCFv MAP ICUS
(mg/d1)
Group I In = 9) : Patients With No Risk Factors for Coronary Artery Disease
IT
1 .5 336 .0 0 .0
1A 2831 14 .0
4 .7 60.0 -5 .6
NL 200
21F 13
117 .6 0.0 2 .2 2818
7
.3
5 .0 10.2 -17 .2
NL
190
3(M 4.9
618 .9 0 .0 3 .8
565 .7 -6 .0 11 .8 0 .0 -18 .2 NL 171
4F
7.7 491 .0
-4.2
2 .5
199 .7 _21 .3 11 .7 29 .9 -15 .6 NL 225
S.'F
10 .6 426 .3
0 .0
-
525 .0 -13 .1
13 .2 0 .0 -11 .3 NL
216
61M
10 .4 300 .0 110
4 .7 &A0 _4A 13 .9 66 .7 -10 .0 N L 186
U 6.0 196 .3 0 .0
3 .7
183 .3
-2 .6 7 .5 0.0 -0 .0 NL M-1
SIF -29 .3 146 .2 8 .2 21 .0
185 .7 9.6 12 .4
114 .3
-13 .3 NL 210
WIF -1 .2 6150 .0
--6 .1 9.3 650.0 -6.1 6 .0
11 .1 -18 .4 N L 220
Mean
1 .3 360 .71' -0 .2 6.1t
386.1 4 -3 .0 9 .6 1, 32 .5 12,2* 198
SD III 180 3 .7
6 .1 1831 7 .7 3 .5 316 5 .0 20
Group 11 (n 17) : Patients With Risk Factors for Coronary Artery Disease
Ifl
4110.0 -15.0 NI. 198
VF 6.4 4 .8 11 .8 317 .3
-83 14 .9 AI3NL 210
3/F -6.8 71 .2 -2 .3 2 .5 2000
-9.8 12 .4 52 .9 NL 200
4/F
-7 .7 83 .3
0 .0
1 .0
150.0
-7 .3 10 .6 14 .3 10 .9 NL 232
51F -7 .8 31 .3 -2 .3
187
.2 1 .3 19 .6 0 .0 -22 .2 NL 324
6/F -19 .8 81 .8 5 .3 428.9 -2 .2 8 .6 0.0
7 .8
NL 153
7IR 750.0
0 .0 NL 183
111W
- - -
21 .6 566.7 -2.7 24 .1 0.0 -6.8 NL 04
91K
- -
-
-3.4 242 .9 2,2 17
.4
36 .8
71
ABNL
407
1 m
-11 .5 400.0
-2.0
-
195 .5 0.0 19 .0 0 .0 8.7
ABNL
228
I IIF -14 .9 150.0 7 .1 -6 .2 NWA 2.0 11 .9 A I ABNL
238
121F
-73
25 .0 0.0 -2 .4 275 .0 1%2 10
.5
11 .4 -116 N1. 250
INF -6 .8 91 .1 0.0 --1 .0 450.0
-51
45 .5 -5 .6 ABNL 574
14M -15 .3 -33 .3 -25 .5
433
3414 -11 .2 19 .9 35 .4 -16 .4 NL
158
IRF
- 42
.0 87.5 -7 .4 -6.1 200.0 -51 13 .5 0 .0 -7 .8 ABNL 152
16&1
-27 .5 240.0
-1 .1 0.8 240.9 2 .5 12 .9 33 .3 -11 .5 ABNL 159
171r -42 .0 288.9 5 .3 9 .4 462 .5 2 .5 13 .7 17 .7
0 .0 N L 229
Alan _16 .61° 117 .2 -14 3 .5 B&3* 02 14 .6' 15 .9 WK
241
SD
12 .4
118 .5 8 .0 8 .4 157 .1 4 .3 4 .3 19 .7 6.1
104
No of pts 13
13 13 12 0 17 IS 15 15 17
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Table 3. Response to Vasoactive Drugs : Percent Change From
__"-A__
Before
	
After
ACETYLCHOUNE
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Coronaqfloiv relocity . In Group 1, acetylcholine caused
a marked increase in coronary flow velocity of 365 t 185%
(p < O .W01), whereas in Group 11 the changw in coronary
flow velocity was blunted (117 ± 118%, p = 0,008) (Fig . 6) .
Data for the four Group 11 patients who had spasm followed
by total occlusion of the vessel during acetylcholine infusion
were excluded . The change in flow velocity thus overesti-
mates the group response . Changes in coronary flow velocity
after acetylcholine were significantly different between
groups (p = 0.012). Papaverine or adenosine caused a
significant increase in coronary flow velocity in both groups
(386 ± 184% in Group 1, p < 0 .001 ; 330 ± 157% in Group IL
p < 0.001). Groups I and 11 were not different in their
response to papaverine or adenosine (p = 0 .325) . Nitroglyc-
erin caused a transient, slight increase (p == NS) in coronary
flow velocity in both groups (33 ": 38% in Group I (p =- 1098)
and 16 ± 20% in Group 11 (p = 0 .02). The two groups were
not different in their response to nitroglycerin (p = 0 .120) .
There was no significant relation between cholesterol and
the coronary flow index response to acetylcholine .
Coronary flow index . Acetylcholine increased corona ry
flow index by 378 ± 203% (p < (1002) in Group I ; in Group
11 the change in this index was much less (75 ± 93%, p =
aseline
1'p<9
.(Wl versus Group I . t p <0
.02 versus Gro"P It . +,p <0
.01 versus Group It . Valu's prcsenled are mean value ± SD . Pts = patients ; other abbreviations
as in Table 2 .
(1029) (Fig. 7). The change in coronary flow index after
acetylcholine was significantly less in Group 11 than in Group
I (p = 0 .001). Conversely, papaverine or adenosine caused a
marked increase in coronary flow index in both groups
(396 ± 200% in Group 1, p < 0 .001 ; 326 ± 161% in Group 11,
p < 0.0001) (Fig, 8) . Groups I and 11 were not different in
their response to papaverine or adenosine (p = 0 .103) .
Nitroglycerin caused a transient increase in coronary flow
index in both groups (45 ± 43% in Group 1, p < 0 .03; 33 ±
22% in Group 11, p < 0 .001) (Fig . 9). The two groups were
not different in their response to nitroglycerin (p = 0 .281) .
There was no significant relation between cholesterol and
the coronary flow index response to acetylcholine .
Coronary vascular resistance index . In Group 1, acetyl-
chWine caused a significant decrease in coronary vascular
resistance index by -73 ± 16% (p < 0 . 1), whereas the
change in coronary vascular resistance index was less in
Group 11 (-31 ± 28%, p = 0 .008). Responses in Groups I
Figure 2 . Change in epicardial coronary artery lumen area (mm') in
response to acetylcholine infusion in Groups I (left) and II (right) .
Individual patient values are connected . Group data are expressed
as mean value ± SD . The p value reflects paired i test results .
4
0
EPICARDIAL AREA
Group 2
Before
After
ACETYLCHOLINE
Group 1 5 = 9)
Group II to = i7 ;
No. of
Pts Act-I
No. of
Pts
NTG
No of
RS PARADE
No . of
Pts ACII
No. of
Rs
NTG
No
. 0 i
Pis PAP/ADE
Epi area 9 1 .3 9 9.6±3 .5 8 6.1±6
.1 B -16.6± 12 .4 15 14.6±4 .3 12 3.5±8
.4
MCFV 9 364 ± 185t 9 33 ± 38 9 386 e 184 13
117 ± 118 15 16 ± 20 17 330 ± 157
Coronary flow index
9 378 ± 2032
9 45 ± 43 8 396 ± 200 13 75 ± 93 15
33 ± 22 12 326 ± 161
Coronary vascular
resistance index
9 -73 ± 16` 9 -35 ± 16 8 -77 ± 9
13 -31 ± 28 15 -31 ± 11 12 - 74 ± 8
Heart rate 9 -0,8±8.2
9
139±- 13 .3 9 1 .6±14 .0 13 -2.3±7 .7
15 7.8±- 6 .9 17 4.4±9 .1
MAP 9 -0.2°±3 .7 9 -12.2±5 .9 9
-3.0t77
13 -1.4±8
15
-10.9±6
.1 0 -2.2±7 .5
24
EPICARDIAL AREA
Group 1
24
20
20
P<0.001
i a
I I
Is
12
a
838
and 11 were significantly different (p = 0 .009) . Papaverine or
adenosine caused a significant decrease in coronary vascular
resistance index in both groups (-77 t 901o in Group I [p <
0.0001] vs. -74 t 8% in Group 11 [p < 0.0001]) . Responses
in Groups I and 11 were not different (p = 0.419) . Nitroglyc-
erin also caused a very transient decrease in coronary
Figure 4. Change in epicardial artery lumen area
(MR1
2
) in response
to nitroglycerin infusion in Groups I (left) and 11 WOO. Data are
expressed as in Figure 2 .
EPMARDIAL AREA
Group I
24
20
18
12
a
4
0
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Before
	
After
NITROGLYCERIN
0
vascular resistance index in both groups (-35 ± 16% in
Group I [p < 0.0001] vs. -31 ± 11% in Group II fr <
0.0001]) . Responses in Groups I and II were not different
(p :7- 0.426) .
Thus, in Group I patients, acetylcholine infusion resulted
in vasodilation of the epicardial artery and significant vaso-
dilation of the coronary microvascuiature, as evidenced by
an increase in coronary flow velocity and a decrease in
coronary vascular resistance index . Conversely, in Group 11
patients, acetylcholine infusion resulted in vasoconstriction
EPICARDIAL AREA
Group 2
After
NITROGLYCERIN
'AV Vol
. 23, No
. 4
.rch 15,1994 :833-43
Figure 3 . Angiograms (top) and ultra-
sound in .ages (bottom) from a patient
in Group 11 with angiographically and
ultrasonically normal coronary artei-
ies (the position of the ultrasound
transducer is noted by the black at-
rewheads on the angiograms) . A,
Baseline
. B, Acetylcholine infusion .
C, Nitroglycerin infusion . On-line di-
ameter measurements are shown in
the upper right of each ultrasound
image. Calibration tie marks are
I
Mm
apart .
24 -
20 -
P<0.0001
18 -
12
a
4 L
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(often severe) of the epicardial artery, with markedly im-
paired dilation of the coronary resistance vessels . In Group
II there was no significant difference in response to au=yl-
choline infusion between those with and without disease
by intracoropqry ultrasound . The epicardial vasodilator re-
sponse to nitroglycerin infusion, an endothelium-independent
agent, was intact in both groups . The microvasculature
vasodilator response to endothelium-independent agents
such as papaverine or adenosine was also intact in both
groups. This selective endothelium-dependent abnormality
can be visualized by comparing the flow change after ace-
EPICARDIAL AREA
Group I
&	
0
160
140
120
80
100
BASELINE PAP
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CFV (PHASIC)
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f 20=G
180
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1140
EPICARDIAL AREA
Group 2
ftlars
After
PAPAVERINE/ADENOSINE
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Figure 5. Change in epicardial artery lumen area (mm 2 ) in response
to papaverine or adenosine infusion in Groups I (left) and II (right) .
Data are expressed as in Figure 2 .
Figure 6. Representative original recording from a patient in Group
11 with hypercholesterolemia . Both coronary angiography and ultra-
sound were normal. Left, Coronary flow velocity (CFV) responses
to the endotheNmi-independent vasodilator papaverine (PAP)
(14-mg bolus) . The flow increase is 195% . Right, responses to the
endothelium-dependent vasodilator acetylcholine (ACH) . The flow
increase is markedly blunted (32%) . EKG = electrocardiogram .
ri ME . 1
840
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Flpre 7. Change in coronary flow index in response to acetylcho-
line infusion in Groups I and 11 . Data are expressed as in Figure 2 .
tykholine infusion with that after papaverine or adenosine
infusion (Fig. 10). Whereas Group I patients had nearly
equivalent responses to both acetylcholine and papaverine
or adenosine, the relation in Group II patients has a much
lower slope (blunted acetylcholine response) and poorer
correlation .
Discussion
The major finding of this study is that administration of
acetylcholine (an endothelium-dependent vasodilator) in-
duced epicardial artery vasoconstriction (often severe) and
abnormally impaired microvascular dilation in patients with
Figure L Change in coronary flow index in response to papaverine
or adenosine infusion in Groups I and IL Data are expressed as in
Figure 2 .
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risk factors for coronary artery disease but normal coronary
arteries by both angiography and intracoronary ultrasound
imaging. The vasodilator response to the endothelium-
independent agents nitroglycerin and papaverine or ade-
nosine was intact in these patients . These data provide in
vivo evidence for isolated endothelial dysfunction in patients
with risk factors for coronary artery disease before the
development of measurable atherosclerosis .
Previm studies of endothellum-dependent epicairdial ar-
tery response . Acetylcholine causes direct muscarinic re-
ceptor-mediated vasoconstriction and endothelium-derived
relaxing factor-mediated vasodilation . The net response of a
vascular bed to acetylcholine depends on the interplay
between these two effects (17) . In truly normal vessels,
acetylcholine has been shown to cause predominantly vaso-
dilation mediated by the release of endothelium-derived
relaxing factor (20) . Acetylcholine conversely causes vaso-
constriction in angiographically atherosclerotic vessels
(10,21), suggesting that clinically evident atherosclerosis
results in endothelial dysfunction . This has been studied
CORONARY FLOW INDEX
Group 2
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further in vitro, where endothelium-derived relaxing factor
release has been found to be impaired in atherosclerotic
vessel segments (22) .
Recent studies in patients with risk factors for coronary
artery disease and angiographically normal coronary arteries
have also demonstrated a vasoconstrictor response in epi-
cardial arteries after infusion of acetylcholine (8-10) . It is
not known from these studies whether the "angiographically
normal" coronary arteries were truly normal or had early or
minimal diffuse atherosclerosis undetectable by angiogra-
phy. Previous pathologic and ultrasound studies have dem-
onstrated that significant atherosclerosis may be present in
angiographically "normal" arterial segments (11-14) . The
unique feature of our study is that, in contrast to previous
studies (9,10), we used intracoronary ultrasound imaging, a
much more sensitive tool, to detect early atherosclerosis .
Although the majority of patients in this study had no
evidence of atherosclerosis by intracoronary ultrasound
Figure 10 . Comparison of change in coronary flow index for acetyl-
choline and papaverine (PAP) or adenosine (ADE) . The relation for
Group I is expressed by the equation y = 0 .66x + 106 ; r = 0 .62,
p < 0 .01 . The relation for Group 11 is expressed by the equation
y = -0.02x + 65 ; r = -0.05, p = 0.887 .
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Figure 9 . Change in coronary flow index in response to nitroglycerin
infusion in Groups I and 11 . Data are expressed as in Figure 1
imaging, seven patients did have very early atherosclerosis,
as seen by ultrasound imaging of their angiographically
normal study vessel. Thus, although it is possible that many
of the angiographically "normal" coronary arteries in pre-
vio)us studies (9,10) were truly normal, it is likely that a
significant number had disease not detected by angiography .
Previous studies of endothelium-dependent microvascular
response . Although much information has been gathered
with regard to the epicardial arteries, eriothelial dysfunc-
tion of these conduit vessels contribute ite to the regula-
tion of tissue perfusion in the absence of vascular spasm .
Myocardial perfusion is regulated predominantly by the
coronary microvasculature . We included provocative testing
of the microvasculature in our study and found evidence of
selective endothelial dysfunction at this level . In monkeys,
chronic hypercholesterolemia has been shown to markedly
impair the vasodilator response to acetylcholine in the
coronary microvasculature where overt atherosclerosis does
not develop (23) . In a recent study, patients with hypercho-
lesterolemia were also shown to have selective impairment
of vasodilation (,i the microvasculature in response to ace-
tylcholine (10). The response of the coronary microvascula-
ture to acetylcholine was shown to be endothelium depen-
dent in previous studies using methylene blue, a known
endothelium-derived relaxing factor blocking agent (17) . In
the present study, we showed that not only hypercholester-
olemia but also other risk factors for coronary artery disease
can cause endothelial dysfunction of the microvasculature,
as evidenced by a selective abnormality of the response io
acetylcholine .
The results from our study thus confirm available data
from animal (2-7) and human (8-10) studies that endothelial
dysfunction may be associated with risk factors for coronary
artery disease and precede the development of structurally
842
evident atherosclerosis . Our data expand this understanding
by providing in vivo evidence that these changes may occur
in structurally normal vessels, as assessed by intravascular
ultrasound . Because it precedes clinically evident athero-
sclerotic changes, endothelial dysfunction may be one of the
important initiating mechanisms for atherosclerosis (24,25) .
Also, impaired endothelium-derived relaxing factor release
from dysfunctional endothelium may promote platelet aggre-
gation (26,27) and platelet-induced contractions of vascular
smooth muscle, leading to ischemic events mediated by
vasospasm .
Study Kniftations . One potential limitation of this study is
the resolution of intravascular ultrasound imaging . Although
irtravascular ultrasound imaging is superior to angiography,
it would not detect structural abnormalities limited to the
cells of the endothelium or involving only a few cell layers of
the intima. The possibility that early fibrofatty streaks (28)
were present in our patients also cannot be excluded .
Whether such changes were also present in Group I patients
cannot be excluded. Another possible limitatioa of the study
is the lack of ECG gating during ultrasound imaging . Dia-
stolic frames were identified on the basis of visual estimation
of the region of cardiac diastasis . Cardiac motion resulting
from each systole was readily apparent . This was identified
by repeated slow playback of the ultrasound images . Errors
were minimized by averaging three successive frames . Pa-
paverine was used in the earlier patients to test the ftdiction
of the microvasculature . In later studies, we used adenosine
instead because of its superior safety profile . Overall, five
patients in Group I and six patients in Group 11 received
papaverine . Although there are theoretic differences in the
mechanisms of action of these two agents, the overall effect
of the two drugs on the microvasculature is similar (29) .
Drug infusion was perform .-d in the left main coronary
artery, and therefore mixing in the left anterior descending
and left circumflex coronary arteries may have been vari-
able. Finally, there was a time delay when the ultrasound
catheter was exchanged for the velocity catheter . This delay
was generally <10 min and allowed a return to baseline
levels after nitroglycerin administration . The potential ef'ect
of two complete infusion protocols on the results cannot be
assessed in this study . However, development of Doppler
velocity guide wires should make simultaneous measure-
ments feasible in the future .
Clinical Implications . The assessment of endothelia! mod-
ulation of vasomotor tone in the catheterization laboratory
may add a new dimension to the evaluation of coronary
artery disease in patients with angiographically normal or
minimally diseased vessels and provide an etiologic basis for
angina in these patients . In animal studies, dietary treatment
(4), administration of 3-hydroxy-3-methylglutaryl-coenzyme
A reductase inhibitors (30) and L-arginine (31) have been
shown to restore hypercholesterolemia-induced endothelial
dysfunction to normal . Similarly, antihypertensive treatment
has been shown to restore hypertension-induced endothelial
dysfunction in rats (32)
. Whether endothelial function in
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humans can be modulated by altering blood pressure or lipid
values is unknown . Preliminary studies have shown, how-
ever, that lowering cholesterol by 29% resulted in improve-
ment in endothelial function in patients with normal coro-
nary arteries (33) . Evaluation of endothelial function may
therefore provide a unique opportunity to intervene very
early in the process of atherogenesis in patients at high risk
for developing coronary atherosclerosis .
We thank Lori Bryant and James Berry for technical assistance, the cathe-
terization laboratory staff for support . Saeid B . Amini, PhD, MBA for statistical
calculations, Marc D . Thames for critical review of the data and Sandra Vincent
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